Reuters logo
BRIEF-Ultragenyx proposes to acquire Dimension Therapeutics for $5.50 per share in cash
September 18, 2017 / 12:39 PM / a month ago

BRIEF-Ultragenyx proposes to acquire Dimension Therapeutics for $5.50 per share in cash

Sept 18 (Reuters) - Ultragenyx Pharmaceutical Inc

* Ultragenyx proposes to acquire Dimension Therapeutics for $5.50 per share in cash

* Ultragenyx Pharmaceutical Inc - ‍proposal has been approved by board of directors of Ultragenyx​

* Ultragenyx Pharmaceutical Inc - ‍has made a proposal to acquire all of outstanding shares of common stock of Dimension Therapeutics for about $138 million​

* Ultragenyx Pharmaceutical Inc - ‍Ultragenyx would fund proposed transaction from cash resources on its balance sheet​

* Ultragenyx Pharmaceutical - ‍proposed all-cash transaction structured as a tender offer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below